Asarinin was considered a promising anti migraine candidate. It showed good binding affinity (−10.3 kcal/mol) with CGRP receptor (PDB: 6ZHO). Network analysis highlighted the major proteins that interacted with the targets of migraine with aura such as OPRM1, GNB1, and GNAS. This evidence concerns the gene GNAS and migraine disorder.